Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Leucémies chroniques
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A phase 2, randomized, open-label study to evaluate ECG results and pharmacokinetic parameters for fludarabine, cyclophosphamide, and rituximab (FCR) in combination with lumiliximab versus FCR alone in subjects with previously untreated chronic lymphocytic leukaemia.
Scientific Abstract
en cours d'intégration;